RxSight (RXST) Competitors $44.81 -0.31 (-0.69%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends RXST vs. BHC, CLPT, EDAP, APYX, STIM, BLCO, INSP, PRCT, AXNX, and NVSTShould you be buying RxSight stock or one of its competitors? The main competitors of RxSight include Bausch Health Companies (BHC), ClearPoint Neuro (CLPT), Edap Tms (EDAP), Apyx Medical (APYX), Neuronetics (STIM), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Axonics (AXNX), and Envista (NVST). These companies are all part of the "medical" sector. RxSight vs. Bausch Health Companies ClearPoint Neuro Edap Tms Apyx Medical Neuronetics Bausch + Lomb Inspire Medical Systems PROCEPT BioRobotics Axonics Envista Bausch Health Companies (NYSE:BHC) and RxSight (NASDAQ:RXST) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability. Does the media prefer BHC or RXST? In the previous week, RxSight had 12 more articles in the media than Bausch Health Companies. MarketBeat recorded 14 mentions for RxSight and 2 mentions for Bausch Health Companies. Bausch Health Companies' average media sentiment score of 1.19 beat RxSight's score of 0.59 indicating that Bausch Health Companies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bausch Health Companies 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RxSight 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in BHC or RXST? 78.7% of Bausch Health Companies shares are held by institutional investors. Comparatively, 78.8% of RxSight shares are held by institutional investors. 8.1% of Bausch Health Companies shares are held by insiders. Comparatively, 9.4% of RxSight shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is BHC or RXST more profitable? Bausch Health Companies has a net margin of -1.88% compared to RxSight's net margin of -23.92%. RxSight's return on equity of -14.00% beat Bausch Health Companies' return on equity.Company Net Margins Return on Equity Return on Assets Bausch Health Companies-1.88% -755.86% 5.11% RxSight -23.92%-14.00%-12.51% Which has higher valuation and earnings, BHC or RXST? RxSight has lower revenue, but higher earnings than Bausch Health Companies. RxSight is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBausch Health Companies$8.76B0.34-$592M-$0.48-17.07RxSight$89.08M20.27-$48.61M-$0.83-53.99 Do analysts prefer BHC or RXST? Bausch Health Companies presently has a consensus target price of $7.75, indicating a potential downside of 5.43%. RxSight has a consensus target price of $61.63, indicating a potential upside of 37.53%. Given RxSight's stronger consensus rating and higher possible upside, analysts plainly believe RxSight is more favorable than Bausch Health Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 1 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00RxSight 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community favor BHC or RXST? Bausch Health Companies received 314 more outperform votes than RxSight when rated by MarketBeat users. However, 71.43% of users gave RxSight an outperform vote while only 61.47% of users gave Bausch Health Companies an outperform vote. CompanyUnderperformOutperformBausch Health CompaniesOutperform Votes35961.47% Underperform Votes22538.53% RxSightOutperform Votes4571.43% Underperform Votes1828.57% Which has more risk & volatility, BHC or RXST? Bausch Health Companies has a beta of 0.74, suggesting that its stock price is 26% less volatile than the S&P 500. Comparatively, RxSight has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. SummaryRxSight beats Bausch Health Companies on 11 of the 18 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get RxSight News Delivered to You Automatically Sign up to receive the latest news and ratings for RXST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RXST vs. The Competition Export to ExcelMetricRxSightOphthalmic goods IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.82B$11.35B$5.05B$8.87BDividend YieldN/A1.63%4.97%4.06%P/E Ratio-53.9925.1197.3414.18Price / Sales20.275.691,218.4289.42Price / CashN/A17.3033.5132.79Price / Book6.513.155.805.12Net Income-$48.61M$224.33M$119.07M$225.99M7 Day Performance1.47%1.40%-1.83%-1.32%1 Month Performance-11.30%-0.34%-3.64%0.60%1 Year Performance61.77%18.64%31.62%26.23% RxSight Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RXSTRxSight3.0052 of 5 stars$44.81-0.7%$61.63+37.5%+58.7%$1.82B$89.08M-53.99220Insider TradeBHCBausch Health Companies3.4347 of 5 stars$8.20+0.1%$7.75-5.4%+16.3%$3.01B$8.76B-17.0720,270Positive NewsCLPTClearPoint Neuro0.7546 of 5 stars$10.96-0.1%$11.33+3.4%+88.2%$302.60M$23.95M0.00110EDAPEdap Tms2.4619 of 5 stars$2.45+2.5%$19.00+675.5%-45.7%$90.90M$65.42M-4.08307Analyst DowngradeAPYXApyx Medical1.4466 of 5 stars$1.40+9.4%N/A-39.1%$52.70M$48.54M-1.58270STIMNeuronetics2.796 of 5 stars$0.80+6.6%$4.67+481.5%-40.6%$22.92M$71.35M0.00180BLCOBausch + Lomb2.7887 of 5 stars$19.39-0.8%$20.91+7.8%+23.2%$6.83B$4.68B-18.4713,300INSPInspire Medical Systems4.91 of 5 stars$184.88+5.0%$233.58+26.3%+29.2%$5.28B$624.80M172.781,011Analyst UpgradePositive NewsGap UpPRCTPROCEPT BioRobotics1.5836 of 5 stars$92.70-0.9%$89.50-3.5%+180.7%$4.88B$136.19M0.00626AXNXAxonics3.2556 of 5 stars$70.98flat$71.00+0.0%N/A$3.63B$366.38M-591.45610News CoverageNVSTEnvista3.8665 of 5 stars$20.37+0.5%$20.71+1.7%-14.3%$3.49B$2.57B0.0012,800 Related Companies and Tools Related Companies Bausch Health Companies Alternatives ClearPoint Neuro Alternatives Edap Tms Alternatives Apyx Medical Alternatives Neuronetics Alternatives Bausch + Lomb Alternatives Inspire Medical Systems Alternatives PROCEPT BioRobotics Alternatives Axonics Alternatives Envista Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RXST) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RxSight, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RxSight With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
